Tilray medical introduces cannabis edibles in australia

Sydney, april 17, 2025 (globe newswire) -- tilray medical (“tilray”), a division of tilray brands, inc. (nasdaq: tlry and tsx: tlry), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, has announced the availability of its medical cannabis edibles, good supply pastilles, to patients in australia. this launch marks tilray medical's first medical cannabis edible offering in the country, providing patients with a sugar-free and vegan-friendly treatment option.
TLRY Ratings Summary
TLRY Quant Ranking